WST Stock Recent News
WST LATEST HEADLINES
EXTON, Pa. , Feb. 28, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Barclays 26th Annual Global Healthcare Conference in Miami, FL on Tuesday, March 12, 2024, at 1:05 PM ET. It will also present at the KeyBanc Virtual Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, at 9:00 AM ET.
West Pharmaceutical Services is a global manufacturer specializing in advanced containment and delivery systems for injectable drugs and healthcare products. The company has a strong focus on high-value products and strategic collaborations, positioning it for future growth in the healthcare sector. Despite current challenges and a somewhat lofty valuation, projected earnings growth suggests the potential for significant long-term returns.
West Pharmaceutical's (WST) fourth-quarter results reflect a strong demand for non-COVID-19 products, especially HVP devices.
West Pharmaceutical Services, Inc. (WST) Q4 2023 Earnings Call Transcript
Although the revenue and EPS for West Pharmaceutical (WST) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
The company had warned in recent months that its clients were slowing down their purchasing.
West Pharmaceutical Services (WST) came out with quarterly earnings of $1.83 per share, beating the Zacks Consensus Estimate of $1.78 per share. This compares to earnings of $1.77 per share a year ago.
West Pharmaceutical Services forecast full-year results below analysts' estimates on Thursday after the company missed fourth-quarter revenue expectations, hurt by weak demand for its medical equipments used to make COVID-19 vaccines.
West Pharmaceutical's (WST) fourth-quarter 2023 results are likely to reflect strength in the Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
Get a deeper insight into the potential performance of West Pharmaceutical (WST) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.